Keywords: مثبت گیرنده استروژن; Wnt; Wingless-related integration site gene; p53; tumor protein p53; Pd/C; palladium on carbon; HCl; hydrochloric acid; (ER+); estrogen receptor-positive; (ERâ); estrogen receptor-negative; (PRâ); progesterone receptor-negative; (HER2â); human epide
مقالات ISI مثبت گیرنده استروژن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data
Keywords: مثبت گیرنده استروژن; ER+; estrogen receptor-positive; ERâ; ER-negative; miRNAs; microRNA; lncRNAs; long non-coding RNAs; C2orf71; chromosome 2 open reading frame 71; ER; estrogen receptor; ncRNA; non-coding RNA; BPs; biological processes; BCAR4; breast cancer anti-estrogen
Neoadjuvant endocrine therapy in breast cancer patients
Keywords: مثبت گیرنده استروژن; Breast cancer; Neoadjuvant treatment; Endocrine therapy; Estrogen receptor-positive; Breast conserving surgery;
Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: A comparative study with Exemestane
Keywords: مثبت گیرنده استروژن; Estrogen receptor-positive breast cancer; Aromatase inhibitors; Exemestane metabolites; Apoptosis; Autophagy; Acquired-resistance; AIs; aromatase inhibitors; AO; acridine orange; AVOs; acid vesicular organelles; CCCP; carbonyl cyanide m-chlorophenylhydraz
Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting
Keywords: مثبت گیرنده استروژن; Gene expression; Breast cancer; Endocrine therapy; Tamoxifen; Progression-free survival; DCIS; ductal carcinoma in situ; EMC; Rotterdam Dutch cohort; ER; estrogen receptor; ER+; estrogen receptor-positive; ERBB2; HER2/ERBB2 mRNA level; ESR1; estrogen rece
Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive (ER+) advanced breast cancer: A review of the literature
Keywords: مثبت گیرنده استروژن; Estrogen receptor-positive; Breast cancer; Economic burden; Societal burden; Second-line breast cancer treatment; Breast cancer recurrence
Clinical experience of using oncotype DX as an additional treatment decision tool in early breast cancer – A retrospective analysis from 5 Greek institutions
Keywords: مثبت گیرنده استروژن; Adjuvant; Breast cancer; Chemotherapy; Estrogen receptor-positive; Multigene assay; Recurrence score
DNA site-specific N3-adenine methylation targeted to estrogen receptor-positive cells
Keywords: مثبت گیرنده استروژن; FNOTXVZCRJUJHO-UHFFFAOYSA-N; CLFQPILSIJHCDR-VEQMNXKASA-N; DLVFYGTVQDMLBR-VEQMNXKASA-N; N3-methyladenine; DNA damage; Breast cancer; Estrogen receptor; Cell-targeting; Sequence-specific DNA methylation; 3-MeA; N3-methyladenine; 7-MeG; N7-methylguanine; EC5
Start strong or switch? Adjuvant endocrine strategies for postmenopausal women with hormone-sensitive breast cancer
Keywords: مثبت گیرنده استروژن; Aromatase inhibitors; Letrozole; Anastrozole; Exemestane; Breast cancer; ABCSG; Austrian Breast and Colorectal Study Group; AIs; aromatase inhibitors; ARNO; Arimidex-Nolvadex; ATAC; Arimidex, Tamoxifen, Alone or in Combination; BIG 1-98; Breast Internat
Aromatase Inhibitors: An Overview for Surgeons
Keywords: مثبت گیرنده استروژن; ABCSG; Austrian Breast and Colorectal Study Group; ARNO; Arimidex-Nolvadex Trial; ATAC; Anastrozole Tamoxifen Alone or in Combination Trial; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER+; estrogen receptor-positive; IBIS; International B